Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2013

01.09.2013 | Epidemiology

Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women

verfasst von: Aparna R. Parikh, Celia Patricia Kaplan, Nancy J. Burke, Jennifer Livaudais-Toman, E. Shelley Hwang, Leah S. Karliner

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

While not itself life-threatening, ductal carcinoma in situ (DCIS) can progress to invasive disease if untreated, and confers an increased risk of future breast cancer. We investigated knowledge of DCIS among a cohort of English- and Spanish-speaking Latina and English-speaking non-Latina white women previously treated for DCIS. We examined knowledge of DCIS with four true/false statements about risk of invasive disease, breast cancer recurrence, and prognosis. For each knowledge statement, we modeled the odds of a correct answer by language–ethnicity (English-speaking Latinas, Spanish-speaking Latinas, and English-speaking whites) adjusting for demographics, health history, and treatment factors. Of 710 participants, 52 % were English-speaking whites, 21 % English-speaking Latinas, and 27 % Spanish-speaking Latinas. Less than half (41 %) of participants were aware that DCIS is not life-threatening and only 32 % knew that surgical treatment choice does not impact mortality; whereas two-thirds (67 %) understood that DCIS confers increased risk of future breast cancer, and almost all (92 %) knew that DCIS, if untreated, could become invasive. Only three Spanish-speakers used professional interpreters during discussions with their physicians. In adjusted analyses, compared to English-speaking whites, both English- and Spanish-speaking Latinas had significantly lower odds of knowing that DCIS was not life-threatening (OR, 95 % CI 0.6, 0.4–0.9 and 0.5, 0.3–0.9, respectively). In contrast, Spanish-speaking Latinas had a twofold higher odds of knowing that DCIS increases risk of future breast cancer (OR, 95 % CI 2.6, 1.6–4.4), but English-speaking Latinas were no different from English-speaking whites. Our data suggest that physicians are more successful at conveying the risks conferred by DCIS than the nuances of DCIS as a non-life-threatening diagnosis. This uneven communication is most marked for Spanish-speaking Latinas. In addition to the use of professional interpreters, efforts to create culturally and linguistically standardized information could improve knowledge and engagement in informed decision making for all DCIS patients.
Literatur
1.
Zurück zum Zitat Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH 2nd, Waldman F (2003) Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 95(22):1692–1702PubMedCrossRef Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH 2nd, Waldman F (2003) Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 95(22):1692–1702PubMedCrossRef
2.
Zurück zum Zitat Rebner M, Raju U (1994) Noninvasive breast cancer. Radiology 190(3):623–631PubMed Rebner M, Raju U (1994) Noninvasive breast cancer. Radiology 190(3):623–631PubMed
4.
Zurück zum Zitat Erbas B, Provenzano E, Armes J, Gertig D (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97(2):135–144PubMedCrossRef Erbas B, Provenzano E, Armes J, Gertig D (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97(2):135–144PubMedCrossRef
5.
Zurück zum Zitat Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102(3):170–178PubMedCrossRef Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102(3):170–178PubMedCrossRef
6.
Zurück zum Zitat Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86(3):429–438PubMedCrossRef Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86(3):429–438PubMedCrossRef
7.
Zurück zum Zitat Group EBCC, Group ER, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381–3387CrossRef Group EBCC, Group ER, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24(21):3381–3387CrossRef
8.
Zurück zum Zitat Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC (2005) The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 104(9):1840–1848PubMedCrossRef Warren JL, Weaver DL, Bocklage T, Key CR, Platz CE, Cronin KA, Ballard-Barbash R, Willey SC, Harlan LC (2005) The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer 104(9):1840–1848PubMedCrossRef
9.
Zurück zum Zitat Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA et al (2010) National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 102(3):161–169PubMedCrossRef Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA et al (2010) National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 102(3):161–169PubMedCrossRef
10.
Zurück zum Zitat Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ (2012) Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin 62(3):203–210PubMedCrossRef Partridge AH, Elmore JG, Saslow D, McCaskill-Stevens W, Schnitt SJ (2012) Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin 62(3):203–210PubMedCrossRef
11.
Zurück zum Zitat Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP (2001) Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med 10(6):589–598PubMedCrossRef Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP (2001) Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Womens Health Gend Based Med 10(6):589–598PubMedCrossRef
12.
Zurück zum Zitat Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B (2011) Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions. Eur J Cancer Care (Engl) 20(6):776–784CrossRef Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B (2011) Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions. Eur J Cancer Care (Engl) 20(6):776–784CrossRef
13.
Zurück zum Zitat De Morgan S, Redman S, D’Este C, Rogers K (2011) Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns 84(1):62–68PubMedCrossRef De Morgan S, Redman S, D’Este C, Rogers K (2011) Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns 84(1):62–68PubMedCrossRef
14.
Zurück zum Zitat Janz NK, Hawley ST, Mujahid MS, Griggs JJ, Alderman A, Hamilton AS, Graff JJ, Jagsi R, Katz SJ (2011) Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer 117(9):1827–1836PubMedCrossRef Janz NK, Hawley ST, Mujahid MS, Griggs JJ, Alderman A, Hamilton AS, Graff JJ, Jagsi R, Katz SJ (2011) Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer. Cancer 117(9):1827–1836PubMedCrossRef
15.
Zurück zum Zitat Karliner LS, Hwang ES, Nickleach D, Kaplan CP (2011) Language barriers and patient-centered breast cancer care. Patient Educ Couns 84(2):223–228PubMedCrossRef Karliner LS, Hwang ES, Nickleach D, Kaplan CP (2011) Language barriers and patient-centered breast cancer care. Patient Educ Couns 84(2):223–228PubMedCrossRef
16.
Zurück zum Zitat Fagerlin A, Lakhani I, Lantz PM, Janz NK, Morrow M, Schwartz K, Deapen D, Salem B, Liu L, Katz SJ (2006) An informed decision? breast cancer patients and their knowledge about treatment. Patient Educ Couns 64(1–3):303–312PubMedCrossRef Fagerlin A, Lakhani I, Lantz PM, Janz NK, Morrow M, Schwartz K, Deapen D, Salem B, Liu L, Katz SJ (2006) An informed decision? breast cancer patients and their knowledge about treatment. Patient Educ Couns 64(1–3):303–312PubMedCrossRef
17.
Zurück zum Zitat Kaplan CP, Napoles AM, Hwang ES, Bloom J, Stewart S, Nickleach D, Karliner L (2011) Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health (Larchmt) 20(2):215–223CrossRef Kaplan CP, Napoles AM, Hwang ES, Bloom J, Stewart S, Nickleach D, Karliner L (2011) Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ. J Womens Health (Larchmt) 20(2):215–223CrossRef
18.
Zurück zum Zitat Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100(4):243–251PubMedCrossRef Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K et al (2008) Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst 100(4):243–251PubMedCrossRef
19.
Zurück zum Zitat Napoles-Springer AM, Livaudais JC, Bloom J, Hwang S, Kaplan CP (2007) Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ. J Psychosoc Oncol 25(4):19–36PubMedCrossRef Napoles-Springer AM, Livaudais JC, Bloom J, Hwang S, Kaplan CP (2007) Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ. J Psychosoc Oncol 25(4):19–36PubMedCrossRef
20.
Zurück zum Zitat McWilliam CL, Brown JB, Stewart M (2000) Breast cancer patients’ experiences of patient-doctor communication: a working relationship. Patient Educ Couns 39(2–3):191–204PubMedCrossRef McWilliam CL, Brown JB, Stewart M (2000) Breast cancer patients’ experiences of patient-doctor communication: a working relationship. Patient Educ Couns 39(2–3):191–204PubMedCrossRef
21.
Zurück zum Zitat Siminoff LA, Ravdin P, Colabianchi N, Sturm CM (2000) Doctor–patient communication patterns in breast cancer adjuvant therapy discussions. Health Expect 3(1):26–36PubMedCrossRef Siminoff LA, Ravdin P, Colabianchi N, Sturm CM (2000) Doctor–patient communication patterns in breast cancer adjuvant therapy discussions. Health Expect 3(1):26–36PubMedCrossRef
22.
Zurück zum Zitat Karliner LS, Jacobs EA, Chen AH, Mutha S (2007) Do professional interpreters improve clinical care for patients with limited English proficiency? a systematic review of the literature. Health Serv Res 42(2):727–754PubMedCrossRef Karliner LS, Jacobs EA, Chen AH, Mutha S (2007) Do professional interpreters improve clinical care for patients with limited English proficiency? a systematic review of the literature. Health Serv Res 42(2):727–754PubMedCrossRef
23.
Zurück zum Zitat Schenker Y, Lo B, Ettinger KM, Fernandez A (2008) Navigating language barriers under difficult circumstances. Ann Intern Med 149(4):264–269PubMedCrossRef Schenker Y, Lo B, Ettinger KM, Fernandez A (2008) Navigating language barriers under difficult circumstances. Ann Intern Med 149(4):264–269PubMedCrossRef
25.
Zurück zum Zitat Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Ellis MJ, Jeffe DB (2010) A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat 124(3):835–844PubMedCrossRef Liu Y, Perez M, Schootman M, Aft RL, Gillanders WE, Ellis MJ, Jeffe DB (2010) A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer. Breast Cancer Res Treat 124(3):835–844PubMedCrossRef
Metadaten
Titel
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women
verfasst von
Aparna R. Parikh
Celia Patricia Kaplan
Nancy J. Burke
Jennifer Livaudais-Toman
E. Shelley Hwang
Leah S. Karliner
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2676-x

Weitere Artikel der Ausgabe 2/2013

Breast Cancer Research and Treatment 2/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.